Last reviewed · How we verify
Post Acute Sequelae of COVID-19 (PASC)
COVID-19, a novel coronavirus, has caused widespread mortality and morbidity since it emerged in 2019. There is ongoing research and growing literature describing severe acute respiratory syndrome (SARS-COV-2). There is a growing population of individuals who have recovered from acute SARS-COV-2 infection. The long-term effects of COVID-19 are unknown. There are growing reports of sequelae after acute SARS-CoV-2 not limited to fatigue, dyspnea, reactive airway disease, organizing pneumonia, pulmonary fibrosis, pulmonary hypertension, pulmonary emboli, and tracheal disease. The incidence and natural history of these findings is unstudied.
Details
| Lead sponsor | Vanderbilt University Medical Center |
|---|---|
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 500 |
| Start date | Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Covid19
- Sars-CoV-2 Infection
- Dyspnea Caused by 2019-nCoV
- COVID-19 Acute Respiratory Distress Syndrome
- Pulmonary Fibrosis
Interventions
- Cohort study
Countries
United States